Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of oral ARN-75039 in healthy adults has completed, in the context of developing therapy for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lassa Fever

Drugs mentioned

• ARN-75039

Snippet

Sponsor: Arisan Therapeutics, Inc. | Conditions: Lassa Virus Infection | Phase 1 | Status: COMPLETED